Home / Pharmacology / Enzymes / Kinases / Hexokinases / Hexokinases Activators / PF 04937319

PF 04937319

Cat. No. 6049 Submit a Review Datasheet / COA / SDS

Discontinued Product

PF 04937319 (Cat. No. 6049) has been withdrawn from sale for commercial reasons.
Description: Glucokinase partial activator
Chemical Name: N,N-Dimethyl-5-[[2-methyl-6-[[(5-methyl-2-pyrazinyl)amino]carbonyl]-4-benzofuranyl]oxy]-2-pyrimidinecarboxamide
Purity: ≥98% (HPLC)
Datasheet
Citations
Reviews
Literature (2)
Biological Activity Technical Data Datasheets References

Biological Activity for PF 04937319

PF 04937319 is a glucokinase partial activator (EC50 = 174 nM). Enhances glucose-stimulated insulin secretion in islet cell cultures and translocation of glucokinase from the nucleus to the cytoplasm in hepatocytes in vitro. Reduces post-prandial plasma glucose levels in an oral glucose tolerance test in rats.

Licensing Information

Sold for research purposes under agreement from Pfizer Inc.

Technical Data for PF 04937319

M. Wt 432.43
Formula C22H20N6O4
Storage Store at +4°C
Purity ≥98% (HPLC)
CAS Number 1245603-92-2
PubChem ID 46916694
InChI Key MASKQITXHVYVFL-UHFFFAOYSA-N
Smiles CC1=CC2=C(OC3=CN=C(C(N(C)C)=O)N=C3)C=C(C(NC4=CN=C(C)C=N4)=O)C=C2O1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

References for PF 04937319

References are publications that support the biological activity of the product.

Pfefferkorn et al (2011) Designing glucokinase activators with reduced hypoglycemia risk: discovery of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 di Med.Chem.Commun., 2 828

Pettersen et al (2014) The relationship of glucokinase activator-induced hypoglycemia with arteriopathy, neuronal necrosis, and peripheral neuropathy in nonclinical studies. Toxicol. Pathol. 42 696 PMID: 24771080

View Related Products by Target

View Related Products by Product Action

View all Hexokinases Activators

Keywords: PF 04937319, PF 04937319 supplier, PF04937319, Glucokinase, partial, activators, activates, type, 2, diabetes, Hexokinases, 6049, Tocris Bioscience

Citations for PF 04937319

Citations are publications that use Tocris products.

Currently there are no citations for PF 04937319.

Reviews for PF 04937319

There are currently no reviews for this product. Be the first to review PF 04937319 and earn rewards!

Have you used PF 04937319?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

Cancer Metabolism Research Product Guide

Cancer Metabolism Research Product Guide

This product guide reviews some of the main areas in cancer metabolism research and lists around 150 products that can be used to investigate metabolic pathways in cancer including:

Cancer Metabolism Poster

Cancer Metabolism Poster

This poster summarizes the main metabolic pathways in cancer cells and highlights potential targets for cancer therapeutics. Genetic changes and epigenetic modifications in cancer cells alter the regulation of cellular metabolic pathways providing potential cancer therapeutic targets.